Adam M. Brufsky, MD, PhD, discusses remaining challenges in breast cancer.
Jason J. Luke, MD, FACP, discusses the treatment landscape of metastatic melanoma.
Antoinette Wozniak, MD, FACP, FASCO, discusses sequencing with immunotherapy and chemoradiation in select patients with stage III lung cancer.
Timothy F. Burns, MD, PhD, discusses methods of identifying genetic alterations in lung cancer.
Liza C. Villaruz, MD, discusses the data with immunotherapy in squamous non–small cell lung cancer.
We traveled to Pittsburgh, Pennsylvania, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from the University of Pittsburgh Medical Center faculty.
Timothy F. Burns, MD, PhD, discusses the frontline standards of care in EGFR-, ALK-, and ROS1-positive non–small cell lung cancer, optimal sequencing strategies, and the nuances of tissue- and plasma-based sequencing.
Antoinette Wozniak, MD, FACP, FASCO, discusses the promise of immunotherapy in lung cancer and shared ongoing research efforts further exploring this approach.